Quality of Life and Clinical Symptom Improvement Support Prostatic Artery Embolization for Patients with Acute Urinary Retention Caused by Benign Prostatic Hyperplasia

Carregando...
Imagem de Miniatura
Citações na Scopus
135
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, v.24, n.4, p.535-542, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose: To show that prostatic artery embolization (PAE) improves quality of life (QoL) and lower urinary tract symptoms in patients with acute urinary retention caused by benign prostatic hyperplasia (BPH). Materials and Methods: This was a single-center prospective study of PAE in 11 patients with BPH managed With indwelling. urinary catheters. International Prostate Symptom Score (IPSS), ultrasound, magnetic resonance (MR) imaging, QoL, and urodynamic tests were used. to assess outcomes. Prostate size ranged from 30 to 90 g, and embolizations were performed with 300-500-mu m Embosphere microspheres. Results: The rate of technical success (ie, bilateral PAE) was 75%, and the rate of clinical success (ie, catheter removal and symptom improvement) was 91% (10 of 11 patients). Postembolization syndrome manifested as mild pain in the perineum, retropubic area, and/or urethra. Ten of 11 patients urinated spontaneously after Foley catheter removal 4-25 days after PAE (mean, 12.1 d). No major complications Were observed. Follow-up ranged from 19 to 48 months. than asymptomatic patient, a discrete area of hypoperfusion: suggesting small ischemia of the bladder was observed on 30-day MR imaging follow-up, but the bladder was normal on 90-day MR imaging. After 1 year, mean prostate volume reduction was greater than 30%, symptoms were mild (mean IPSS, 2.8 +/- 2.1; P = .04),. no erectile dysfunction was observed, and QoL,improved significantly (mean , 0.4 +/- 0.5; P = .001) using the paired t test. Conclusions: Patients with severe symptoms and acute urinary retention caused by BPH can be treated Safely by PAE, which improves clinical symptoms and QoL.
Palavras-chave
Referências
  1. American Urological Association, 2010, GUID MAN BEN PROST H
  2. Bilhim T, 2012, J VASC INTERV RADIOL, V23, P1403, DOI 10.1016/j.jvir.2012.07.028
  3. Carnevale FC, 2011, CARDIOVASC INTER RAD, V34, P1330, DOI 10.1007/s00270-011-0136-8
  4. Carnevale FC, 2010, CARDIOVASC INTER RAD, V33, P355, DOI 10.1007/s00270-009-9727-z
  5. CHUTE CG, 1993, J UROLOGY, V150, P85
  6. DeMeritt JS, 2000, J VASC INTERV RADIOL, V11, P767, DOI 10.1016/S1051-0443(07)61638-8
  7. Emberton M, 2003, UROLOGY, V61, P267, DOI 10.1016/S0090-4295(02)02371-3
  8. Kaplan Steven A, 2005, Rev Urol, V7 Suppl 8, pS34
  9. Kuntz RM, 2004, J UROLOGY, V172, P1012, DOI 10.1097/01.ju.0000136218.11998.9e
  10. McVary KT, 2006, AM J MANAG CARE, V12, pS122
  11. Michel F, 2002, J UROLOGY, V168, P2550, DOI 10.1097/01.ju.0000036371.49460.7d
  12. Muzzonigro G, 2004, J UROLOGY, V172, P611, DOI 10.1097/01.ju.0000131258.36966.dI
  13. National Cancer Institute, 2009, US DEP HLTH HUM SERV, V09-5410
  14. Pisco JM, 2011, J VASC INTERV RADIOL, V22, P11, DOI 10.1016/j.jvir.2010.09.030
  15. Rassweiler J, 2006, EUR UROL, V50, P969, DOI 10.1016/j.eururo.2005.12.042
  16. Rastinehad AR, 2008, UROLOGY, V71, P181, DOI 10.1016/j.urology.2007.09.012
  17. Sacks David, 2003, J Vasc Interv Radiol, V14, pS199
  18. WASSON JH, 1995, NEW ENGL J MED, V332, P75, DOI 10.1056/NEJM199501123320202
  19. Ziada A, 1999, UROLOGY, V53, P1, DOI 10.1016/S0090-4295(98)00532-9